Renal Osteodystrophy
Renal osteodystrophy is a bone disorder that develops as a direct consequence of chronic kidney disease (CKD). When the kidneys lose their ability to filter waste and regulate minerals, calcium and phosphate levels fall out of balance, and the body stops converting vitamin D into its active form. The result is weakened, brittle bone tissue that fractures more easily and causes persistent aching, particularly in the hips, knees, and lower back.
Medicine used to treat Renal Osteodystrophy
Why the kidneys matter for bone health
Healthy kidneys activate vitamin D, which the body needs to absorb calcium from food. In CKD, this conversion breaks down. Low active vitamin D triggers the parathyroid glands to overproduce parathyroid hormone (PTH), which then pulls calcium directly from bone to compensate. Over months and years, this cycle erodes bone density and alters bone structure. Treatment focuses on restoring that missing active vitamin D; calcitriol is the synthetic form most often used to suppress PTH and slow bone loss. Managing this condition is a core part of bone health in people living with kidney disease.
Persistent bone pain, muscle weakness, or unexplained fractures in someone with CKD warrant prompt review by a kidney specialist, as untreated secondary hyperparathyroidism can progress rapidly.